Cargando…
Glypican-1 Overexpression in Different Types of Breast Cancers
PURPOSE: Treatment of metastatic breast cancer patients is challenging and remains a major underlying cause of female mortality. Understanding molecular alterations in tumor development is critical to identify novel biomarkers and targets for cancer diagnosis and therapy. One of the aberrant cancer...
Autores principales: | Alshammari, Fatemah O F O, Al-Saraireh, Yousef M, Youssef, Ahmed M M, AL-sarayra, Yahya M, Alrawashdeh, Hamzeh Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334627/ https://www.ncbi.nlm.nih.gov/pubmed/34366675 http://dx.doi.org/10.2147/OTT.S315200 |
Ejemplares similares
-
Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers
por: Al-Saraireh, Yousef M, et al.
Publicado: (2021) -
Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study
por: Alshammari, Fatemah O F O, et al.
Publicado: (2021) -
Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer
por: Alshammari, Fatemah OFO, et al.
Publicado: (2022) -
Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer
por: Al-saraireh, Yousef M., et al.
Publicado: (2021) -
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
por: Al-saraireh, Yousef M, et al.
Publicado: (2021)